Ultimately, the present findings may also provide a translational advantage by considering maternal hyperlipidemia and the FGF-PI3K/AKT- PGC1α cluster as a targetable hub for prevention and treatment of developmentally programmed heart disease. The gene discussed is AKT1; the disease is heart disorder.